Document:

Exhibit 10.4

 

 

 

SECURITY
AGREEMENT

 

dated
as of April 17, 2020

 

by

 

H-CYTE,
INC.

 

AND

 

ITS
SUBSIDIARIES

 

as
Grantors,

 

in
favor of

 

FWHC
BRIDGE, LLC,

as
Agent for the Secured Parties

 

 

 

    	 	 	 

    	 	 	 

    

 

Table
of Contents

 

	 	Page
	 	 
	Article
    1 DEFINED TERMS	3
	SECTION
    1.1.	Terms
    Defined in the Uniform Commercial Code.	3
	SECTION
    1.2.	Definitions.	3
	SECTION
    1.3.	Other
    Definitional Provisions.	7
	 	 	 
	Article
    2 SECURITY INTEREST 	8
	SECTION
    2.1.	Grant
    of Security Interest.	8
	 	 	 
	Article
    3 REPRESENTATIONS AND WARRANTIES	9
	SECTION
    3.1.	Existence.	9
	SECTION
    3.2.	Authorization
    of Agreement; No Conflict.	9
	SECTION
    3.3.	Enforceability.	9
	SECTION
    3.4.	Consents.	9
	SECTION
    3.5.	Perfected
    Liens.	10
	SECTION
    3.6.	Title,
    No Other Liens.	10
	SECTION
    3.7.	State
    of Organization; Location of Inventory, Equipment and Fixtures; other Information.	10
	SECTION
    3.8.	Other
    Collateral.	10
	SECTION
    3.9.	Intellectual
    Property.	11
	SECTION
    3.10.	Investment
    Property; Partnership/LLC Interests.	11
	 	 	 
	Article
    4 COVENANTS	11
	SECTION
    4.1.	Maintenance
    of Perfected Security Interest; Further Information.	11
	SECTION
    4.2.	Maintenance
    of Insurance.	11
	SECTION
    4.3.	Changes
    in Locations; Changes in Name or Structure.	11
	SECTION
    4.4.	Required
    Notifications.	12
	SECTION
    4.5.	Filing
    Covenants.	12
	SECTION
    4.6.	Accounts.	12
	SECTION
    4.7.	Intellectual
    Property.	12
	SECTION
    4.8.	Investment
    Property; Partnership/LLC Interests.	13
	SECTION
    4.9.	Further
    Assurances.	14
	 	 	 
	Article
    5 REMEDIAL PROVISIONS	14
	SECTION
    5.1.	General
    Remedies.	14
	SECTION
    5.2.	Specific
    Remedies.	15
	SECTION
    5.3.	Application
    of Proceeds.	16
	SECTION
    5.4.	Waiver,
    Deficiency.	16
	 	 	 
	Article
    6 THE AGENT	17
	SECTION
    6.1.	Agent’s
    Appointment as Attorney-In-Fact.	17
	SECTION
    6.2.	Duty
    of Agent With Respect to the Collateral.	18
	 	 	 
	Article
    7 MISCELLANEOUS	19
	SECTION
    7.1.	Amendments
    in Writing.	19
	SECTION
    7.2.	Notices.	19
	SECTION
    7.3.	No
    Waiver by Course of Conduct, Cumulative Remedies.	19
	SECTION
    7.4.	Enforcement
    Expenses, Indemnification.	19
	SECTION
    7.5.	Set-Off.	20
	SECTION
    7.6.	Successors
    and Assigns.	20
	SECTION
    7.7.	Signatures;
    Counterparts.	20
	SECTION
    7.8.	Severability.	20
	SECTION
    7.9.	Section
    Heading.	21
	SECTION
    7.10.	Integration.	21
	SECTION
    7.11.	Governing
    Law.	21
	SECTION
    7.12.	Jurisdiction,
    Jury Trial Waiver, Etc.	21
	SECTION
    7.13.	Acknowledgements.	22
	SECTION
    7.14.	Additional
    Grantors.	22
	SECTION
    7.15.	Releases.	22
	SECTION
    7.16.	No
    Conflicts with Enforcement; Release.	22

 

    	 	i	 

     

    

 

This
SECURITY AGREEMENT (this “Agreement”), dated as of April 17, 2020, by and among H-CYTE, INC., a Nevada corporation
(the “Company”), the existing subsidiaries of the Company, as set forth on Schedule 3.7 attached hereto,
as such Schedule 3.7 may be updated from time to time, and any Additional Grantor (as defined below) who may become a party
to this Agreement (such Additional Grantors, collectively with the Company and its subsidiaries, the “Grantors”
and each individually a “Grantor”), in favor of FWHC Bridge, LLC, a Delaware limited liability company, as
collateral agent (in such capacity, the “Agent”) for the ratable benefit of itself and the other Purchasers
(collectively with the Agent, the “Secured Parties” and each, a “Secured Party”) from time
to time party to the Purchase Agreement described below, by and among the Company and the Purchasers.

 

STATEMENT
OF PURPOSE

 

WHEREAS,
the Company and the Purchasers have previously entered into (i) the Secured Convertible Note and Warrant Purchase Agreement, dated
as of the date hereof (the “Purchase Agreement”), pursuant to which the Company sold and issued secured convertible
promissory notes to the Purchasers (the “Notes”);

 

WHEREAS,
it is a condition precedent to the obligation of the Purchasers to advance funds to the Company that the Grantors shall have executed
and delivered this Agreement to the Agent for the ratable benefit of the Purchasers.

 

NOW,
THEREFORE, for good and valuable consideration, the receipt and sufficiency of which are hereby acknowledged by the parties hereto,
the Grantors hereby agree with the Agent as follows:

 

Article
1

 

DEFINED
TERMS

 

SECTION
1.1. Terms Defined in the Uniform Commercial Code.

 

(a)
The following terms when used in this Agreement shall have the meanings assigned to them in the UCC (as defined below) as in effect
from time to time: “Account”, “Account Debtor”, “Authenticate”, “Certificated
Security”, “Chattel Paper”; “Commercial Tort Claim”, “Deposit Account”,
“Documents”, “Electronic Chattel Paper”, “Equipment”, “Fixture”,
“General Intangible”, “Instrument”, “Inventory”, “Investment
Company Security”, “Investment Property”, “Letter of Credit Rights”, “Proceeds”,
“Record”, “Registered Organization”, “Security”, “Securities
Entitlement”, “Securities Intermediary”, “Securities Account”, “Supporting
Obligation”, “Tangible Chattel Paper”, and “Uncertificated Security”.

 

(b)
Terms defined in the UCC and not otherwise defined herein or in the Notes or the Purchase Agreement shall have the meaning assigned
in the UCC as in effect from time to time.

 

SECTION
1.2. Definitions. The following terms when used in this Agreement shall have the meanings assigned to them below:

 

“Additional
Grantor” means each subsidiary of the Grantors which is formed or acquired after the date hereof pursuant to Section
7.14.

 

“Advances”
means all advances made by Purchasers pursuant to the Purchase Agreement.

 

    	 	 	 

    	 	 	 

    

 

“Agreement”
means this Security Agreement, as amended, restated, supplemented or otherwise modified from time to time.

 

“Affiliate”
means, with respect to any specified Person, any other Person who or which, directly or indirectly, controls, is controlled by,
or is under common control with such specified Person, including, without limitation, any general partner, officer, director,
managing member or manager of such Person or any venture capital fund now or hereafter existing that is controlled by one or more
general partners or managing members of, or shares the same management company with, such Person.

 

“Business
Day” means any day except Saturday, Sunday, or a federal holiday in the United States.

 

“Collateral”
has the meaning assigned thereto in Section 2.1.

 

“Contractual
Obligation” means, as to any Person, any provision of any security issued by such Person or of any agreement, instrument
or other undertaking to which such Person is a party or by which it or any of its property is bound.

 

“Control”
means the manner in which “control” is achieved under the UCC with respect to any Collateral for which the UCC specifies
a method of achieving “control”.

 

“Copyrights”
means collectively, all of the following: (a) all copyrights, rights and interests in copyrights, works protectable by copyright,
copyright registrations and copyright applications anywhere in the world, (b) all reissues, extensions, continuations (in whole
or in part) and renewals of any of the foregoing, (c) all income, royalties, damages and payments now or hereafter due and/or
payable under any of the foregoing or with respect to any of the foregoing, including, without limitation, damages or payments
for past, present or future infringements of any of the foregoing, (d) the right to sue for past, present and future infringements
of any of the foregoing and (e) all rights corresponding to any of the foregoing throughout the world.

 

“Copyright
Licenses” means any written agreement naming any Grantor as licensor or licensee, granting any right under any Copyright,
including, without limitation, the grant of rights to manufacture, distribute, exploit and sell materials derived from any Copyright.

 

“Effective
Endorsement and Assignment” means, with respect to any specific type of Collateral, all such endorsements, assignments
and other instruments of transfer reasonably requested by the Agent with respect to the Security Interest granted in such Collateral,
and in each case, in form and substance satisfactory to the Agent.

 

“Governmental
Authority” means any nation or government, any state, provincial or other political subdivision thereof and any entity
exercising executive, legislative, judicial, regulatory or administrative functions of or pertaining to government.

 

“Government
Contract” means a contract between any Grantor and an agency, department or instrumentality of the United States or
any state, municipal or local Governmental Authority located in the United States or all obligations of any such Governmental
Authority arising under any Account now or hereafter owing by any such Governmental Authority, as Account Debtor, to any Grantor.

 

“Grantors”
has the meaning set forth in the Preamble of this Agreement.

 

    	 	4	 

     

    

 

“Intellectual
Property” means collectively, all of the following: (a) all systems software, applications software and internet rights,
including, without limitation, screen displays and formats, internet domain names, web sites (including web links), program structures,
sequence and organization, all documentation for such software, including, without limitation, user manuals, flowcharts, programmer’s
notes, functional specifications, and operations manuals, all formulas, processes, ideas and know-how embodied in any of the foregoing,
and all program materials, flowcharts, notes and outlines created in connection with any of the foregoing, whether or not patentable
or copyrightable, (b) concepts, discoveries, improvements and ideas, (c) any useful information relating to the items described
in clause (a) or (b), including know-how, technology, engineering drawings, reports, design information, trade secrets, practices,
laboratory notebooks, specifications, test procedures, maintenance manuals, research, development, manufacturing, marketing, merchandising,
selling, purchasing and accounting, (d) Patents and Patent Licenses, Copyrights and Copyright Licenses, Trademarks and Trademark
Licenses, and (e) other licenses to use any of the items described in the foregoing clauses (a), (b), (c) and (d) or any other
similar items of such Grantor necessary for the conduct of its business.

 

“Issuer”
means any issuer of any Investment Property or Partnership/LLC Interests (including, without limitation, any Issuer as defined
in the UCC).

 

“Obligations”
means (i) all monetary obligations, including fees, costs, attorneys’ fees and disbursements, reimbursement obligations,
expenses and indemnities, whether primary, secondary, direct, contingent, fixed or otherwise (including monetary obligations incurred
during the pendency of any bankruptcy, insolvency, receivership or other similar proceeding, regardless of whether allowed or
allowable in such proceeding), of the Company under the Purchase Agreement, the Notes and any other Transaction Document, and
(ii) all other agreements, duties, indebtedness, obligations and liabilities of any kind of the Company under, out of, or in connection
with the Purchase Agreement, the Notes, this Agreement, the other Transaction Documents or any other document made, delivered
or given in connection with any of the foregoing, in each case whether now existing or hereafter arising, whether evidenced by
a note or other writing, whether allowed in any bankruptcy, insolvency, receivership or other similar proceeding, whether arising
from an extension of credit, loan, guaranty, indemnification or otherwise, and whether direct or indirect, absolute or contingent,
due or to become due, primary or secondary, or joint or several.

 

“Partnership/LLC
Interests” means, with respect to any Grantor, the entire partnership, membership interest or limited liability company
interest, as applicable, of such Grantor in each partnership, limited partnership or limited liability company owned thereby,
including, without limitation, such Grantor’s capital account, its interest as a partner or member, as applicable, in the
net cash flow, net profit and net loss, and items of income, gain, loss, deduction and credit of any such partnership, limited
partnership or limited liability company, as applicable, such Grantor’s interest in all distributions made or to be made
by any such partnership, limited partnership or limited liability company, as applicable, to such Grantor and all of the other
economic rights, titles and interests of such Grantor as a partner or member, as applicable, of any such partnership, limited
partnership or limited liability company, as applicable, whether set forth in the partnership agreement or membership agreement,
as applicable, of such partnership, limited partnership or limited liability company, as applicable, by separate agreement or
otherwise.

 

“Patents”
means collectively, all of the following: (a) all patents, rights and interests in patents, patentable inventions and patent applications
anywhere in the world, (b) all reissues, extensions, continuations (in whole or in part) and renewals of any of the foregoing,
(c) all income, royalties, damages or payments now or hereafter due and/or payable under any of the foregoing or with respect
to any of the foregoing, including, without limitation, damages or payments for past, present or future infringements of any of
the foregoing, (d) the right to sue for past, present and future infringements of any of the foregoing and (e) all rights corresponding
to any of the foregoing throughout the world.

 

    	 	5	 

     

    

 

“Patent
License” means all agreements now or hereafter in existence, whether written, implied or oral, providing for the grant
by or to any Grantor of any right to manufacture, use or sell any invention covered in whole or in part by a Patent.

 

“Perfection
Certificate” means that certain Perfection Certificate delivered by the Grantors to the Agent on the date hereof, as
the same may be amendment, supplemented or otherwise modified from time to time.

 

“Permitted
Liens” means:

 

	(a)	Liens
    for taxes, fees, assessments or other governmental charges or levies, either not delinquent or being contested in good faith
    by appropriate proceedings and for which a Grantor maintains adequate reserves;
	 	 
	(b)	Liens
    (i) upon or in any Equipment acquired or held by a Grantor or any of its Subsidiaries to secure the purchase price of such
    Equipment or indebtedness incurred solely for the purpose of financing the acquisition or lease of such Equipment, or (ii)
    existing on such Equipment at the time of its acquisition, provided that the Lien is confined solely to the property so acquired
    and improvements thereon, and the proceeds of such Equipment, it being agreed that this is in addition to Liens listed on
    the Perfection Certificate;
	 	 
	(c)	Liens
    incurred in connection with the extension, renewal or refinancing of the indebtedness secured by Liens of the type described
    in clause (b) above, provided that any extension, renewal or replacement Lien shall be limited to the property encumbered
    by the existing Lien and the principal amount of the indebtedness being extended, renewed or refinanced does not increase;
	 	 
	(d)	Liens
    in favor of other financial institutions arising in connection with a Grantor’s deposit accounts held at such institutions
    to secured standard fees for deposit services charged by, but not financing made available by such institutions, provided
    that Bank has a perfected security interest in the amounts held in such deposit accounts; and
	 	 
	(e)	Liens
    to secure the performance of statutory obligations, surety or appeal bonds, performance bonds or other obligations of a like
    nature incurred in the ordinary course of business.

 

“Person”
means any individual, sole proprietorship, partnership, joint venture, trust, unincorporated association, corporation, limited
liability company, entity or government (whether federal, state, county, city or otherwise, including, without limitation, any
instrumentality, division, agency or department thereof).

 

“Requirement
of Law” means, as to any Person, any law or determination of an arbitrator or a court or other Governmental Authority,
in each case applicable to or binding upon such Person or any of its property or to which such Person or any of its property is
subject.

 

“Security
Interests” means the security interests granted pursuant to Article II, as well as all other security interests
expressly created or assigned as additional security for the Obligations pursuant to the provisions of the Purchase Agreement.

 

    	 	6	 

     

    

 

“Trademarks”
means collectively, all of the following: (a) all trademarks, rights and interests in trademarks, trade names, corporate names,
company names, business names, fictitious business names, trade styles, service marks, logos, other business identifiers, prints
and labels on which any of the foregoing have appeared or appear, whether registered or unregistered, all registrations and recordings
thereof, and all applications in connection therewith (other than each application to register any trademark or service mark prior
to the filing under and acceptance in accordance with any Requirement of Law of a verified statement of use for such trademark
or service mark) anywhere in the world, (b) all reissues, extensions, continuations (in whole or in part) and renewals of any
of the foregoing, (c) all income, royalties, damages and payments now or hereafter due and/or payable under any of the foregoing
or with respect to any of the foregoing, including, without limitation, damages or payments for past, present or future infringements
of any of the foregoing, (d) the right to sue for past, present and future infringements of any of the foregoing and (e) all rights
corresponding to any of the foregoing (including the goodwill) throughout the world.

 

“Trademark
License” means any agreement now or hereafter in existence, whether written or oral, providing for the grant by or to
any Grantor of any right to use any Trademark.

 

“Transaction
Documents” means, collectively, the Purchase Agreement, each Note issued pursuant thereto, each warrant issued pursuant
thereto and this Agreement.

 

“UCC”
means the Uniform Commercial Code as in effect in the State of Florida from time to time; provided, that if by reason of mandatory
provisions of law, the perfection or the effect of perfection or non-perfection of the security interest in any Collateral is
governed by the Uniform Commercial Code as in effect in a jurisdiction other than Florida, “UCC” means the
Uniform Commercial Code as in effect in such other jurisdiction for purposes of the provisions hereof relating to such perfection
or effect of perfection or non-perfection.

 

SECTION
1.3. Other Definitional Provisions. Terms defined in the Purchase Agreement or the Notes and not otherwise defined herein
shall have the meaning assigned thereto in the Purchase Agreement or the Notes, as applicable. With reference to this Agreement,
unless otherwise specified herein: (a) the definitions of terms herein shall apply equally to the singular and plural forms of
the terms defined, (b) whenever the context may require, any pronoun shall include the corresponding masculine, feminine and neuter
forms, (c) the words “include”, “includes” and “including” shall be deemed to be followed
by the phrase “without limitation”, (d) the word “will” shall be construed to have the same meaning and
effect as the word “shall”, (e) any definition of or reference to any agreement, instrument or other document herein
shall be construed as referring to such agreement, instrument or other document, as from time to time amended, supplemented or
otherwise modified (subject to any restrictions on such amendments, supplements or modifications set forth herein), (f) any reference
herein to any Person shall be construed to include such Person’s permitted successors and assigns, (g) the words “herein”,
“hereof” and “hereunder”, and words of similar import, shall be construed to refer to this Agreement in
its entirety and not to any particular provision hereof, (h) all references herein to Articles, Sections, Exhibits and Schedules
shall be construed to refer to Articles and Sections of, and Exhibits and Schedules to, this Agreement, (i) the words “asset”
and “property” shall be construed to have the same meaning and effect and to refer to any and all tangible and intangible
assets and properties, including cash, securities, accounts and contract rights, (j) the term “documents” includes
any and all instruments, documents, agreements, certificates, notices, reports, financial statements and other writings, however
evidenced, whether in physical or electronic form, (k) in the computation of periods of time from a specified date to a later
specified date, the word “from” means “from and including;” the words “to” and “until”
each mean “to but excluding;” and the word “through” means “to and including”, (l) Section
headings herein are included for convenience of reference only and shall not affect the interpretation of this Agreement and (k)
where the context requires, terms relating to the Collateral or any part thereof, when used in relation to a Grantor, shall refer
to such Grantor’s Collateral or the relevant part thereof.

 

    	 	7	 

     

    

 

Article
2

 

SECURITY
INTEREST

 

SECTION
2.1. Grant of Security Interest. Each Grantor hereby grants, pledges and collaterally assigns to the Agent, for the ratable
benefit of the Secured Parties, a security interest in all of such Grantor’s right, title and interest in the following
property, now owned or at any time hereafter acquired by such Grantor or in which such Grantor now has or at any time in the future
may acquire any right, title or interest, and wherever located or deemed located (collectively, the “Collateral”),
as collateral security for the prompt and complete payment and performance when due (whether at the stated maturity, by acceleration
or otherwise) of the Obligations:

 

(a)
all Accounts;

 

(b)
all cash and currency;

 

(c)
all Chattel Paper;

 

(d)
all Commercial Tort Claims, including those identified in the Perfection Certificate;

 

(e)
all Deposit Accounts;

 

(f)
all Documents;

 

(g)
all Equipment;

 

(h)
all Fixtures;

 

(i)
all General Intangibles;

 

(j)
all Instruments;

 

(k)
all Intellectual Property;

 

(l)
all Inventory;

 

(m)
all Investment Property;

 

(n)
all Letter of Credit Rights;

 

(o)
all other personal property not otherwise described above;

 

(p)
all books and records pertaining to the Collateral; and

 

    	 	8	 

     

    

 

(q)
to the extent not otherwise included, all Proceeds and products of any and all of the foregoing and all collateral security and
Supporting Obligations (as now or hereafter defined in the UCC) given by any Person with respect to any of the foregoing, provided,
that (i) the Security Interests granted herein shall not extend to, and the term “Collateral” shall not include (A)
any rights under any lease, contract or agreement (including, without limitation, any license for Intellectual Property) to the
extent that the granting of a security interest therein is specifically prohibited in writing by, or would constitute an event
of default under or would grant a party a termination right either under any Requirement of Law or any provision, term or condition
of any such lease, contract or agreement governing such right unless such prohibition is not enforceable or is otherwise ineffective
under any Requirement of Law, (B) equity interests of a foreign controlled corporation (as defined in the Internal Revenue Code)
in excess of 65% of the voting power of all classes of equity interests of such controlled foreign corporation entitled to vote,
or (C) any rights under any Government Contract or federal or state governmental license or permit to the extent that the granting
of a security interest therein is specifically prohibited by any Requirement of Law. Notwithstanding any of the foregoing, such
proviso shall not affect, limit, restrict or impair the grant by any Grantor of a Security Interest in (x) any Account or any
money or other amounts due and payable to such Grantor or to become due and payable to such Grantor under such lease, contract
or agreement or (y) Proceeds of any federal or state governmental license or permit.

 

Article
3

 

REPRESENTATIONS
AND WARRANTIES

 

Each
Grantor hereby represents and warrants to the Agent for the benefit of the Purchasers as of the date hereof that:

 

SECTION
3.1. Existence. Each Grantor is duly organized, validly existing and in good standing under the laws of the jurisdiction
of its incorporation or formation, has the requisite power and authority to own, lease and operate its properties and to conduct
the business in which it is currently, or is currently proposed to be, engaged and is duly qualified as a foreign entity, licensed
and in good standing under the laws of each jurisdiction where its ownership, lease or operation of property or the conduct of
its business requires such qualification, except to the extent that the failure to so qualify could not have a Material Adverse
Effect.

 

SECTION
3.2. Authorization of Agreement; No Conflict. Each Grantor has the right, power and authority and has taken all necessary
corporate and other action to authorize the execution, delivery and performance of, this Agreement. The execution, delivery and
performance by each Grantor of this Agreement will not, by the passage of time, the giving of notice or otherwise, violate any
provision of such Grantor’s organizational documents, any Contractual Obligation or any Requirement of Law applicable to
such Grantor and will not result in the creation or imposition of any Lien (or obligation to create a Lien), other than the Security
Interests, upon or with respect to any property, asset or business of such Grantor.

 

SECTION
3.3. Enforceability. This Agreement has been duly executed and delivered by the duly authorized officers of each Grantor
and this Agreement constitutes the legal, valid and binding obligation of the Grantors enforceable in accordance with its terms.

 

SECTION
3.4. Consents. No approval, consent, compliance, exemption, authorization or other action by, or notice to, or filing with,
any Governmental Authority or any other Person is necessary or required in connection with the execution, delivery or performance
by, or enforcement against any Grantor or any Issuer of this Agreement, except (a) as may be required by laws affecting the offering
and sale of securities generally, (b) filings with the United States Copyright Office and/or the United States Patent and Trademark
Office, (c) filings under the UCC and/or other applicable law, and (d) as otherwise specified in the Purchase Agreement.

 

    	 	9	 

     

    

 

SECTION
3.5. Perfected Liens. Each financing statement naming any Grantor as a debtor is in appropriate form for filing in the
appropriate filing offices of the states specified on Schedule 3.7. The Security Interests granted pursuant to this Agreement
(a) constitute legal, valid and enforceable security interests in all of the Collateral in favor of the Agent as collateral security
for the Obligations, and (b): upon the filing of UCC-1 financing statements in the applicable jurisdictions and, with respect
to each Deposit Account and Securities Account of each Grantor, upon the execution and delivery of an account control agreement
with respect to such Deposit Account or Securities Account, the Security Interests shall constitute perfected Liens (with respect
to Intellectual Property, if and to the extent perfection may be achieved by the filing of UCC-1 financing statements and/or patent,
trademark or copyright security agreements, as applicable, in the United States Patent and Trademark Office or the United States
Copyright Office) in favor of the Agent, on behalf and for the ratable benefit of the Secured Parties, in the Collateral as collateral
security for the Obligations, which Liens will be prior to all other Liens on the Collateral of such Grantor, subject only to
Permitted Liens, and which are enforceable as such against all creditors of such Grantor and any Person purporting to purchase
such Collateral from such Grantor.

 

SECTION
3.6. Title, No Other Liens. Except for the Security Interests, each Grantor owns each item of the Collateral free and clear
of any and all Liens or claims other than Permitted Liens. No financing statement under the UCC of any state which names a Grantor
as debtor or other public notice with respect to all or any part of the Collateral is on file or of record in any public office,
except such as have been filed in favor of the Agent pursuant to this Agreement or in connection with Permitted Liens.

 

SECTION
3.7. State of Organization; Location of Inventory, Equipment and Fixtures; other Information.

 

(a)
The exact legal name of each Grantor is set forth on Schedule 3.7 (as such schedule may be updated from time to time pursuant
to Section 4.3).

 

(b)
Each Grantor is a Registered Organization organized under the laws of the state identified on Schedule 3.7 under such Grantor’s
name (as such schedule may be updated from time to time pursuant to Section 4.3). The taxpayer identification number and
Registered Organization number of each Grantor is set forth on Schedule 3.7 under such Grantor’s name (as such schedule
may be updated from time to time pursuant to Section 4.3).

 

(c)
The mailing address, principal place of business, chief executive office and office where each Grantor keeps its books and records
relating to the Accounts, Documents, General Intangibles, Instruments and Investment Property in which it has any interest is
located at the locations specified on Schedule 3.7 under such Grantor’s name. No Grantor has any other places of
business except those separately set forth on Schedule 3.7 under such Grantor’s name. No Grantor does business nor
has any Grantor done business during the past five years under any trade name or fictitious business name except as disclosed
on Schedule 3.7 under such Grantor’s name. Except as disclosed on Schedule 3.7, such Grantor has not acquired
assets from any Person, other than assets acquired in the ordinary course of the Grantor’s business, during the past five
years.

 

SECTION
3.8. Other Collateral. No Grantor holds (a) any Chattel Paper in the ordinary course of its business, (b) any Commercial
Tort Claims, (c) any Instruments or is named a payee of any promissory note or other evidence of indebtedness or (d) any Farm
Products or Proceeds of Farm Products. In the event any Grantor shall obtain rights in any such Collateral, Grantors shall promptly
give Agent written notice thereof and shall supplement the Perfection Certificate to include such Collateral.

 

    	 	10	 

     

    

 

SECTION
3.9. Intellectual Property. None of the Intellectual Property is owned by a person other than a Grantor, except for non
exclusive licenses granted by a Grantor to its customers in the ordinary course of business and outbound licenses. To the best
of the Grantors’ knowledge, each of the Copyrights, Trademarks and Patents is valid and enforceable, and no part of the
Intellectual Property Collateral has been judged invalid or unenforceable, in whole or in part, and no claim has been made to
any Grantor that any part of the Intellectual Property violates the rights of any third party except to the extent such claim
could not reasonably be expected to cause a Material Adverse Effect.

 

SECTION
3.10. Investment Property; Partnership/LLC Interests.

 

(a)
All Investment Property and all Partnership/LLC Interests issued by any Issuer to any Grantor (i) have been duly and validly issued
and, if applicable, are fully paid and nonassessable, (ii) are beneficially owned as of record by such Grantor and (ii) constitute
all the issued and outstanding shares of all classes of the capital stock of such Issuer issued to such Grantor.

 

Article
4

 

COVENANTS

 

Until
the Obligations shall have been paid in full, unless consent has been obtained in the manner provided for in Section 7.1,
each Grantor covenants and agrees that:

 

SECTION
4.1. Maintenance of Perfected Security Interest; Further Information.

 

(a)
Each Grantor shall maintain the Security Interest created by this Agreement as a first priority perfected Security Interest (subject
only to Permitted Liens) and shall defend such Security Interest against the claims and demands of all Persons whomsoever (other
than Permitted Liens).

 

(b)
Each Grantor will furnish to the Agent from time to time statements and schedules further identifying and describing the assets
and property of such Grantor and such other reports in connection therewith as the Agent may reasonably request, all in reasonable
detail.

 

SECTION
4.2. Maintenance of Insurance.

 

(a)
The Grantors will maintain, with financially sound and reputable companies, insurance policies (i) insuring the Collateral against
loss by fire, explosion, theft and such other casualties as may be reasonably satisfactory to the Agent in amounts comparable
to amounts of insurance coverage obtained by similar businesses of similar size acting prudently and (ii) insuring each Grantor
and the Agent (for the benefit of the Secured Parties) against liability for personal injury and property damage relating to the
Collateral, such policies to be in such form and amounts and having such coverage as shall be comparable to forms, amounts and
coverage, respectively, obtained by similar businesses of similar size acting prudently.

 

(b)
All insurance referred to in subsection (a) above shall (i) name the Agent as loss payee (to the extent covering risk of loss
or damage to tangible property) and as an additional insured as its interests may appear (to the extent covering any other risk)
and (ii) provide that no cancellation, material reduction in amount or material change in coverage thereof shall be effective
until at least twenty (20) days after receipt by the Agent of written notice thereof.

 

SECTION
4.3. Changes in Locations; Changes in Name or Structure. No Grantor will, except upon thirty (30) days’ prior written
notice to the Agent and delivery to the Agent of (a) all additional financing statements (executed if necessary for any particular
filing jurisdiction) and other instruments and documents reasonably requested by the Agent to maintain the validity, perfection
and priority of the Security Interests and (b) if applicable, a written supplement to the Schedules of this Agreement:

 

(i)
change its jurisdiction of organization from that identified on Schedule 3.7; or

 

    	 	11	 

     

    

 

(ii)
change its name, identity, taxpayer identification number, organizational identification number (if any), type of organization
or corporate or organizational structure to such an extent that any financing statement filed by the Agent in connection with
this Agreement would become misleading.

 

SECTION
4.4. Required Notifications. Each Grantor shall promptly notify the Agent, in writing, of: (a) any Lien (other than the
Security Interests or Permitted Liens) on any of the Collateral which would adversely affect the ability of the Agent to exercise
any of its remedies hereunder, (b) the occurrence of any other event which could reasonably be expected to have a Material Adverse
Effect on the aggregate value of the Collateral or on the Security Interests, and (c) the acquisition or ownership by such Grantor
of any (i) Commercial Tort Claim having a value in excess of $100,000, or (ii) Investment Property in an amount in excess of $100,000
after the date hereof.

 

SECTION
4.5. Filing Covenants. Pursuant to Section 9-509 of the UCC and any other Requirement of Law, each Grantor authorizes the
Agent to file or record financing statements and other filing or recording documents or instruments with respect to the Collateral
without the signature of such Grantor in such form and in such offices as the Agent determines appropriate to perfect the Security
Interests of the Agent under this Agreement. Such financing statements may describe the Collateral in the same manner as described
herein or may contain an indication or description of Collateral that describes such property in any other manner as the Agent
may determine, in its sole discretion, is necessary, advisable or prudent to ensure the perfection of the Security Interest in
the Collateral granted herein, including, without limitation, describing such property as “all assets” or “all
personal property.” Each Grantor hereby authorizes, ratifies and confirms all financing statements and other filing or recording
documents or instruments filed by Agent prior to the date of this Agreement.

 

SECTION
4.6. Accounts.

 

(a)
Other than in the ordinary course of business consistent with its past practice or as such Grantor deems appropriate under the
circumstances in its reasonable business judgment, no Grantor will (i) grant any extension of the time of payment of any Account,
(ii) compromise or settle any Account for less than the full amount thereof, (iii) release, wholly or partially, any Account Debtor,
(iv) allow any credit or discount whatsoever on any Account or (v) amend, supplement or modify any Account in any manner that
could reasonably be likely to adversely affect the value thereof.

 

SECTION
4.7. Intellectual Property.

 

(a)
Grantors shall register or cause to be registered (to the extent not already registered) with the United States Patent and Trademark
Office or the United States Copyright Office, as the case may be, those registrable intellectual property rights now owned or
hereafter developed or acquired by Grantors, to the extent that Grantors, in their reasonable business judgment, deems it appropriate
to so protect such intellectual property rights.

 

(b)
Grantors shall promptly give Agent written notice of any applications or registrations of intellectual property rights filed with
the United States Patent and Trademark Office, including the date of such filing and the registration or application numbers,
if any, and shall supplement the Perfection Certificate to reflect such filings.

 

    	 	12	 

     

    

 

(c)
Grantors shall (i) give Agent not less than thirty (30) days prior written notice of the filing of any applications or registrations
with the United States Copyright Office, including the title of such intellectual property rights to be registered, as such title
will appear on such applications or registrations, and the date such applications or registrations will be filed; (ii) prior to
the filing of any such applications or registrations, execute such documents as Agent may reasonably request for Agent to maintain
its perfection in such intellectual property rights to be registered by a Grantor; (iii) upon the request of Agent, either deliver
to Grantor or file such documents simultaneously with the filing of any such applications or registrations; (iv) upon filing any
such applications or registrations, promptly provide Agent with a copy of such applications or registrations together with any
exhibits, evidence of the filing of any documents requested by Agent to be filed for Agent to maintain the perfection and priority
of its security interest in such intellectual property rights, and the date of such filing.

 

(d)
Grantors shall execute and deliver such additional instruments and documents from time to time as Agent shall reasonably request
to perfect and maintain the perfection and priority of Agent’s security interest in the Intellectual Property.

 

(e)
Grantors shall use commercially reasonably efforts to (i) protect, defend and maintain the validity and enforceability of the
Trademarks, Patents, Copyrights, and trade secrets, (ii) detect infringements of the Trademarks, Patents and Copyrights and promptly
advise Bank in writing of material infringements detected and (iii) not allow any material Trademarks, Patents or Copyrights to
be abandoned, forfeited or dedicated to the public without the written consent of Agent, which shall not be unreasonably withheld.

 

(f)
Agent may audit a Grantor’s Intellectual Property to confirm compliance with this Section, provided such audit may not occur
more often than twice per year, unless an Event of Default has occurred and is continuing. Agent shall have the right, but not
the obligation, to take, at Grantors’ sole expense, any actions that a Grantor is required under this Section to take but
which a Grantor fails to take, after fifteen (15) days’ notice to Grantors. Grantors shall reimburse and indemnify Bank
for all reasonable costs and reasonable expenses incurred in the reasonable exercise of its rights under this Section.

 

SECTION
4.8. Investment Property; Partnership/LLC Interests.

 

(a)
Without the prior written consent of the Agent, no Grantor will (i) vote to enable, or take any other action to permit, any applicable
Issuer to issue to such Grantor any Investment Property or Partnership/LLC Interests, except for such additional Investment Property
or Partnership/LLC Interests that will be subject to the Security Interest granted herein in favor of the Agent, or (ii) enter
into any agreement or undertaking restricting the right or ability of such Grantor or the Agent to sell, assign or transfer any
Investment Property or Partnership/LLC Interests or Proceeds thereof. The Grantors will defend the right, title and interest of
the Agent in and to any Investment Property and Partnership/LLC Interests against the claims and demands of all Persons whomsoever,
other than a Person holding a Permitted Lien on such Investment Property or Partnership/LLC Interests.

 

(b)
If any Grantor shall become entitled to receive or shall receive (i) any Certificated Securities (including, without limitation,
any certificate representing a stock dividend or a distribution in connection with any reclassification, increase or reduction
of capital or any certificate issued in connection with any reorganization), option or rights in respect of the ownership interests
of any Issuer, whether in addition to, in substitution of, as a conversion of, or in exchange for, any Investment Property, or
otherwise in respect thereof, or (ii) upon the occurrence and during the continuation of an Event of Default, any sums paid upon
or in respect of any Investment Property upon the liquidation or dissolution of any Issuer, such Grantor shall accept the same
as the agent of the Agent, hold the same in trust for the Agent, segregated from other funds of the Grantor, and promptly deliver
the same to the Agent in accordance with the terms hereof.

 

    	 	13	 

     

    

 

SECTION
4.9. Further Assurances. Upon the request of the Agent and at the sole expense of the Grantors, each Grantor will promptly
and duly execute and deliver, and have recorded, such further instruments, agreements and documents and take such further actions
as the Agent may reasonably request for the purpose of obtaining or preserving the full benefits of this Agreement and of the
rights and powers herein granted, including, without limitation, (i) the collateral assignment of any material Contractual Obligation,
(ii) the collateral assignment of Government Contracts and notices of assignment, in form and substance satisfactory to the Agent,
duly executed by any Grantors party to such Government Contract in compliance with any applicable laws, and (iii) all applications,
certificates, agreements, instruments, registration statements, and all other documents and papers the Agent may reasonably request
and as may be required by law in connection with the obtaining of any consent, approval, registration, qualification, or authorization
of any Person deemed necessary or appropriate for the effective exercise of any rights under this Agreement. Further, upon the
request of the Agent and at the sole expense of the Grantors, each Grantor will take such reasonable actions and deliver all such
agreements as are requested by the Agent to provide the Agent with Control of all Deposit Accounts, Investment Property, Securities
Accounts, Letter of Credit Rights and Electronic Chattel Paper owned or held by such Grantor.

 

Article
5

 

REMEDIAL
PROVISIONS

 

SECTION
5.1. General Remedies. If an Event of Default shall occur and be continuing, the Agent, in addition to all other rights
and remedies granted to it in this Agreement and in any other instrument or agreement securing, evidencing or relating to the
Obligations, all rights and remedies of a secured party under the UCC or any other applicable law. Without limiting the generality
of the foregoing, the Agent, without demand of performance or other demand, presentment, protest, advertisement or notice of any
kind (except any notice required by law referred to below) to or upon any Grantor or any other Person (all and each of which demands,
defenses, advertisements and notices are hereby waived), may in such circumstances forthwith collect, receive, appropriate and
realize upon the Collateral, or any part thereof, and/or may forthwith sell, lease, assign, give option or options to purchase,
or otherwise dispose of and deliver the Collateral or any part thereof (or contract to do any of the foregoing), in one or more
parcels at public or private sale or sales, at any exchange, broker’s board or office of the Agent or elsewhere upon such
terms and conditions as it may deem advisable and at such prices as it may deem best, for cash or on credit or for future delivery
without assumption of any credit risk. The Agent may disclaim any warranties in connection with any sale or other disposition
of the Collateral, including, without limitation, any warranties of title, possession, quiet enjoyment and the like. The Agent
shall have the right upon any such public sale or sales, and, to the extent permitted by law, upon any such private sale or sales,
to purchase the whole or any part of the Collateral so sold, free of any right or equity of redemption in any Grantor, which right
or equity is hereby waived and released. Each Grantor further agrees, at the Agent’s request, to assemble the Collateral
and make it available to the Agent at places which the Agent shall reasonably select, whether at such Grantor’s premises
or elsewhere. To the extent permitted by applicable law, the Grantor waives all claims, damages and demands it may acquire against
the Agent arising out of the exercise by it of any rights hereunder except to the extent any such claims, damages, or demands
result solely from the gross negligence or willful misconduct of the Agent. If any notice of a proposed sale or other disposition
of Collateral shall be required by law, such notice shall be deemed reasonable and proper if given at least ten (10) days before
such sale or other disposition. Effective upon the occurrence and during the continuance of an Event of Default, the Agent is
hereby granted a license or other right to use, without charge, each Grantor’s labels, Patents, Copyrights, rights of use
of any name, trade secrets, tradenames, Trademarks and advertising matter, or any property of a similar nature, as it pertains
to the Collateral, in advertising for sale and selling any Collateral, and each Grantor’s rights under all licenses and
all franchise agreements shall inure to the Agent’s benefit.

 

    	 	14	 

     

    

 

SECTION
5.2. Specific Remedies.

 

(a)
The Agent hereby authorizes each Grantor to collect such Grantor’s Accounts, under the Agent’s direction and control;
provided that, subject to applicable Requirements of Law, the Agent may curtail or terminate such authority at any time
after the occurrence and during the continuance of an Event of Default.

 

(b)
Upon the occurrence and during the continuance of an Event of Default, subject to applicable Requirements of Law:

 

(i)
the Agent may communicate with Account Debtors of any Account subject to a Security Interest, and upon the request of the Agent,
each Grantor shall notify (such notice to be in form and substance satisfactory to the Agent) its Account Debtors and parties
to the material Contractual Obligations subject to a Security Interest that such Accounts and material Contractual Obligations
have been assigned to the Agent;

 

(ii)
each Grantor shall forward to the Agent, on the last Business Day of each week, deposit slips related to all cash, money, checks
or any other similar items of payment received by the Grantor during such week, and, if requested by the Agent, copies of such
checks or any other similar items of payment, together with a statement showing the application of all payments on the Collateral
during such week and a collection report with regard thereto, in form and substance satisfactory to the Agent;

 

(iii)
the Agent shall have the right to receive any and all cash dividends, payments or distributions made in respect of any Investment
Property or Partnership/LLC Interests other Proceeds paid in respect of any Investment Property or Partnership/LLC Interests,
and any or all of any Investment Property or Partnership/LLC Interests shall be registered in the name of the Agent or its nominee,
and the Agent or its nominee may thereafter exercise (A) all voting, corporate and other rights pertaining to such Investment
Property or Partnership/LLC Interests at any meeting of shareholders, partners or members of the relevant Issuers and (B) any
and all rights of conversion, exchange and subscription and any other rights, privileges or options pertaining to such Investment
Property or Partnership/LLC Interests as if it were the absolute owner thereof (including, without limitation, the right to exchange
at its discretion any and all of the Investment Property or Partnership/LLC Interests upon the merger, consolidation, reorganization,
recapitalization or other fundamental change in the corporate, partnership or company structure of any Issuer or upon the exercise
by any Grantor or the Agent of any right, privilege or option pertaining to such Investment Property or Partnership/LLC Interests,
and in connection therewith, the right to deposit and deliver any and all of the Investment Property or Partnership/LLC Interests
with any committee, depositary, transfer agent, registrar or other designated agency upon such terms and conditions as the Agent
may determine), all without liability except to account for property actually received by it; but the Agent shall have no duty
to any Grantor to exercise any such right, privilege or option and the Agent shall not be responsible for any failure to do so
or delay in so doing. In furtherance thereof, each Grantor hereby authorizes and instructs each Issuer with respect to any Collateral
consisting of Investment Property or Partnership/LLC Interests to (i) comply with any instruction received by it from the Agent
in writing that (A) states that an Event of Default has occurred and is continuing and (B) is otherwise in accordance with the
terms of this Agreement, without any other or further instructions from such Grantor, and each Grantor agrees that each Issuer
shall be fully protected in so complying following receipt of such notice and prior to notice that such Event of Default is no
longer continuing, and (ii) except as otherwise expressly permitted hereby and subject to the provisions of the Subordination
Agreement, pay any dividends, distributions or other payments with respect to any Investment Property or Partnership/LLC Interests
directly to the Agent; and

 

    	 	15	 

     

    

 

(iv)
the Agent shall be entitled to (but shall not be required to): (A) proceed to perform any and all obligations of the applicable
Grantor under any material Contractual Obligation and exercise all rights of such Grantor thereunder as fully as such Grantor
itself could, (B) do all other acts which the Agent may deem necessary or proper to protect its Security Interest granted hereunder,
provided such acts are not inconsistent with or in violation of the terms of the Purchase Agreement, of the other Transaction
Documents or any Requirement of Law, and (C) sell, assign or otherwise transfer any material Contractual Obligation in accordance
with the Purchase Agreement, the other Transaction Documents and any Requirement of Law, subject, however, to the prior approval
of each other party to such material Contractual Obligation, to the extent required under the material Contractual Obligation.

 

(c)
Unless an Event of Default shall have occurred and be continuing and the Agent shall have given notice to the relevant Grantor
of the Agent’s intent to exercise its corresponding rights pursuant to Section 5.2(b), each Grantor shall be permitted
to receive all cash dividends, payments or other distributions made in respect of any Investment Property and Partnership/LLC
Interests, in each case paid in the normal course of business of the relevant Issuer and consistent with past practice, to the
extent permitted in the Purchase Agreement and the other Transaction Documents, and to exercise all voting and other corporate,
company and partnership rights with respect to any Investment Property and Partnership/LLC Interests; provided that, no
vote shall be cast or other corporate, company and partnership right exercised or other action taken which, in the Agent’s
reasonable judgment, would impair the Collateral in any material respect or which would result in an Event of Default under any
provision of the Purchase Agreement, any Note, this Agreement or any other Transaction Document.

 

SECTION
5.3. Application of Proceeds. At such intervals as may be agreed upon by the Company and the Agent, or, if an Event of
Default shall have occurred and be continuing, at any time at the Agent’s election, the Agent may apply all or any part
of the Collateral or any Proceeds of the Collateral in payment in whole or in part of the Obligations (after deducting all reasonable
costs and expenses of every kind incurred in connection therewith or incidental to the care or safekeeping of any of the Collateral
or in any way relating to the Collateral or the rights of the Agent hereunder, including, without limitation, reasonable attorneys’
fees and disbursements) in accordance with the Purchase Agreement. Only after (i) the payment by the Agent of any other amount
required by any provision of law, including, without limitation, Section 9-610 and Section 9-615 of the UCC and (ii) the payment
in full of the Obligations, shall the Agent account for the surplus, if any, to any Grantor, or to whomever may be lawfully entitled
to receive the same (if such Person is not a Grantor).

 

SECTION
5.4. Waiver, Deficiency. Each Grantor hereby waives, to the extent permitted by any Requirement of Law, all rights of redemption,
appraisement, valuation, stay, extension or moratorium now or hereafter in force under any Requirement of Law in order to prevent
or delay the enforcement of this Agreement or the absolute sale of the Collateral or any portion thereof. Each Grantor shall remain
liable for any deficiency if the proceeds of any sale or other disposition of the Collateral are insufficient to pay its Obligations
and the fees and disbursements of any attorneys employed by the Agent to collect such deficiency.

 

    	 	16	 

     

    

 

Article
6

 

THE
AGENT

 

SECTION
6.1. Agent’s Appointment as Attorney-In-Fact.

 

(a)
During the continuance of an Event of Default, each Grantor hereby irrevocably constitutes and appoints the Agent and any officer
or agent thereof, with full power of substitution, as its true and lawful attorney-in-fact with full irrevocable power and authority
in the place and stead of such Grantor and in the name of such Grantor or in its own name, for the purpose of carrying out the
terms of this Agreement, to take any and all appropriate action and to execute any and all documents and instruments which may
be necessary or desirable to accomplish the purposes of this Agreement, and, without limiting the generality of the foregoing,
each Grantor hereby gives the Agent the power and right, on behalf of such Grantor, without notice to or assent by such Grantor,
to do any or all of the following upon the occurrence and during the continuation of an Event of Default, subject to applicable
Requirements of Law:

 

(i)
in the name of such Grantor or its own name, or otherwise, take possession of and indorse and collect any checks, drafts, notes,
acceptances or other instruments for the payment of moneys due under any Account or material Contractual Obligation subject to
a Security Interest or with respect to any other Collateral and file any claim or take any other action or proceeding in any court
of law or equity or otherwise deemed appropriate by the Agent for the purpose of collecting any and all such moneys due under
any Account or material Contractual Obligation subject to a Security Interest or with respect to any other Collateral whenever
payable;

 

(ii)
in the case of any of Grantor’s Intellectual Property, execute and deliver, and have recorded, any and all agreements, instruments,
documents and papers as the Agent may request to evidence the Agent’s security interest in such Intellectual Property and
the goodwill and General Intangibles of such Grantor relating thereto or represented thereby;

 

(iii)
pay or discharge taxes and Liens levied or placed on or threatened against the Collateral, effect any repairs or any insurance
called for by the terms of this Agreement and pay all or any part of the premiums therefor and the costs thereof;

 

(iv)
execute, in connection with any sale provided for in this Agreement, any endorsements, assignments or other instruments of conveyance
or transfer with respect to the Collateral; and

 

(v)
(A) direct any party liable for any payment under any of the Collateral to make payment of any and all moneys due or to become
due thereunder directly to the Agent or as the Agent shall direct; (B) ask or demand for, collect, and receive payment of and
receipt for, any and all moneys, claims and other amounts due or to become due at any time in respect of or arising out of any
Collateral; (C) sign and indorse any invoices, freight or express bills, bills of lading, storage or warehouse receipts, drafts
against debtors, assignments, verifications, notices and other documents in connection with any of the Collateral; (D) commence
and prosecute any suits, actions or proceedings at law or in equity in any court of competent jurisdiction to collect the Collateral
or any portion thereof and to enforce any other right in respect of any Collateral; (E) defend any suit, action or proceeding
brought against such Grantor with respect to any Collateral; (F) settle, compromise or adjust any such suit, action or proceeding
and, in connection therewith, give such discharges or releases as the Agent may deem appropriate; (G) assign any Copyright, Patent
or Trademark (along with the goodwill of the business to which any such Copyright, Patent or Trademark pertains), for such term
or terms, on such conditions, and in such manner, as the Agent shall in its sole discretion determine; and (H) generally, sell,
transfer, pledge and make any agreement with respect to or otherwise deal with any of the Collateral as fully and completely as
though the Agent were the absolute owner thereof for all purposes, and do, at the Agent’s option and such Grantor’s
expense, at any time, or from time to time, all acts and things which the Agent deems necessary to protect, preserve or realize
upon the Collateral and the Agent’s Security Interests therein and to effect the intent of this Agreement, all as fully
and effectively as such Grantor might do.

 

    	 	17	 

     

    

 

(b)
If any Grantor fails to perform or comply with any of its agreements contained herein, the Agent, at its option, but without any
obligation so to do, may perform or comply, or otherwise cause performance or compliance, with such agreement in accordance with
the provisions of Section 6.1(a).

 

(c)
The expenses of the Agent incurred in connection with actions taken pursuant to the terms of this Agreement, together with interest
thereon at a rate per annum equal to five percent (5%), from the date of payment by the Agent to the date reimbursed by relevant
Grantor, shall be payable by such Grantor to the Agent on demand.

 

(d)
Each Grantor hereby ratifies all that said attorneys shall lawfully do or cause to be done by virtue hereof in accordance with
Section 6.1(a). All powers, authorizations and agencies contained in this Agreement are coupled with an interest and are
irrevocable until this Agreement is terminated and the Security Interests created hereby are released.

 

SECTION
6.2. Duty of Agent With Respect to the Collateral.

 

(a)
The Agent’s sole duty with respect to the custody, safekeeping and physical preservation of the Collateral in its possession,
under Section 9-207 of the UCC or otherwise, shall be to deal with it in the same manner as the Agent deals with similar property
for its own account. Neither the Agent nor any of its respective officers, directors, employees or agents shall be liable for
failure to demand, collect or realize upon any of the Collateral or for any delay in doing so or shall be under any obligation
to sell or otherwise dispose of any Collateral upon the request of any Grantor or any other Person or to take any other action
whatsoever with regard to the Collateral or any part thereof. The powers conferred on the Agent hereunder are solely to protect
the Agent’s interests in the Collateral and shall not impose any duty upon the Agent to exercise any such powers. The Agent
shall be accountable only for amounts that it actually receives as a result of the exercise of such powers, and neither it nor
any of its officers, directors, employees or agents shall be responsible to any Grantor for any act or failure to act hereunder,
except for their own willful misconduct.

 

(b)
Nothing set forth in this Agreement or any other Transaction Document, nor the exercise by the Agent of any of the rights or remedies
hereunder, shall relieve any Grantor from the performance of any term, covenant, condition or agreement on such Grantor’s
part to be performed or observed in respect of any of the Collateral or from any liability to any person in respect of any of
the Collateral or shall impose any obligation on the Agent or any other Secured Party to perform or observe any such term, covenant,
condition or agreement on such Grantor’s part to be so performed or observed or shall impose any liability on the Agent
or any other Secured Party for any act or omission on the part of such Grantor relating thereto or for any breach of any representation
or warranty on the part of such Grantor contained in this Agreement, the Purchase Agreement or the other Transaction Documents,
or in respect of the Collateral or made in connection herewith or therewith. Anything herein to the contrary notwithstanding,
neither the Agent nor any other Secured Party shall have any obligation or liability under any contracts, agreements and other
documents included in the Collateral by reason of this Agreement, nor shall the Agent or any other Secured Party be obligated
to perform any of the obligations or duties of any Grantor thereunder or to take any action to collect or enforce any such contract,
agreement or other document included in the Collateral. The obligations of each Grantor contained in this Section 6.2 shall
survive the termination hereof and the discharge of such Grantor’s other obligations under this Agreement, the Purchase
Agreement and the other Transaction Documents.

 

    	 	18	 

     

    

 

Article
7

 

MISCELLANEOUS

 

SECTION
7.1. Amendments in Writing. None of the terms or provisions of this Agreement may be waived, amended, supplemented or otherwise
modified except by a written instrument executed by the Grantors and the Agent. 

 

SECTION
7.2. Notices. All notices, requests and demands to or upon the Agent or any Grantor hereunder shall be effected in the
manner provided for in the Purchase Agreement.

 

SECTION
7.3. No Waiver by Course of Conduct, Cumulative Remedies. The Agent shall not by any act (except by a written instrument
pursuant to Section 7.1), delay, indulgence, omission or otherwise be deemed to have waived any right or remedy hereunder or to
have acquiesced in any Event of Default. No failure to exercise, nor any delay in exercising on the part of the Agent, any right,
power or privilege hereunder shall operate as a waiver thereof. No single or partial exercise of any right, power or privilege
hereunder shall preclude any other or further exercise thereof or the exercise of any other right, power or privilege. A waiver
by the Agent of any right or remedy hereunder on any one occasion shall not be construed as a bar to any right or remedy which
the Agent would otherwise have on any future occasion. The rights and remedies herein provided are cumulative, may be exercised
singly or concurrently and are not exclusive of any other rights or remedies provided by law.

 

SECTION
7.4. Enforcement Expenses, Indemnification.

 

(a)
Each Grantor hereby agrees to indemnify and hold harmless the Agent, each other Secured Party and their Affiliates of any of the
foregoing Persons (each such Person being called an “Indemnitee”)
from any losses, damages, liabilities, claims and related expenses (including the reasonable fees and expenses of any counsel
for any Indemnitee), incurred by any Indemnitee or asserted against any Indemnitee by any Person (including any Grantor), other
than such Indemnitee and its Affiliates, arising out of, in connection with or resulting from this Agreement (including, without
limitation, enforcement of this Agreement) or any failure of any Obligations to be the legal, valid, and binding obligations of
any Grantor enforceable against such Grantor in accordance with their terms, whether brought by a third party or by such Grantor,
and regardless of whether any Indemnitee is a party thereto; provided that such indemnity shall not, as to any Indemnitee, be
available to the extent that such losses, claims, damages, liabilities or related expenses (i) are determined by a court of competent
jurisdiction by final and nonappealable judgment to have resulted from the willful misconduct or gross negligence of any Indemnitee
or (ii) result from a claim brought by any Grantor against an Indemnitee for breach in bad faith of such Indemnitee’s obligations
hereunder or under any other Transaction Document, if such Grantor has obtained a final and nonappealable judgment in its favor
on such claim as determined by a court of competent jurisdiction.

 

(b)
Each Grantor agrees to pay or reimburse the Agent for all its costs and expenses (including reasonable attorneys’ fees)
incurred in collecting against such Grantor its Obligations or otherwise enforcing or preserving any rights under this Agreement
and the other Transaction Documents to which such Grantor is a party, including the fees and other charges of counsel.

 

    	 	19	 

     

    

 

(c)
To the fullest extent permitted by applicable law, each Grantor shall not assert, and hereby waives, any claim against any Indemnitee,
on any theory of liability, for special, indirect, consequential or punitive damages (as opposed to direct or actual damages)
arising out of, in connection with, or as a result of, this Agreement, any other Transaction Document or any agreement or instrument
contemplated hereby or the transactions contemplated hereby or thereby. No Indemnitee referred to in this Section 7.4 shall
be liable for any damages arising from the use by unintended recipients of any information or other materials distributed by it
through telecommunications, electronic or other information transmission systems in connection with this Agreement or the other
Transaction Documents or the transactions contemplated hereby or thereby, except for their own willful misconduct or gross negligence
and other than to account for the monies actually received by Agent in accordance with the terms of this Agreement.

 

(d)
Notwithstanding the termination of this Agreement, the indemnities to which the Agent and the other Secured Parties are entitled
under the provisions of this Section 7.4 and any other provision of this Agreement and the other Transaction Documents
shall continue in full force and effect and shall protect the Agent and the other Secured Parties against events arising after
termination of this Agreement as well as before.

 

(e)
All amounts due under this Section shall be payable promptly after demand therefor, shall constitute Obligations and shall bear
interest until paid at five percent (5%) per annum at which interest would then be payable on any past due payment under the Notes.

 

SECTION
7.5. Set-Off. Upon the occurrence and during the continuation of an Event of Default, in addition to all other rights and
remedies that may then be available to any Secured Party, each such Secured Party is hereby authorized at any time and from time
to time, without prior notice to such Grantor (any such notice being expressly waived by each Grantor) to setoff and apply any
and all indebtedness at any time owing by such Secured Party to or for the credit or the account of any Grantor against all amounts
which may be owed to such Secured Party by such Grantor in connection with this Agreement or any other Transaction Document.

 

SECTION
7.6. Successors and Assigns. This Agreement shall be binding upon the successors and assigns of each Grantor and shall
inure to the benefit of each Grantor (and shall bind all Persons who become bound as a Grantor to this Security Agreement), the
Agent and the other Purchasers and their respective successors and assigns; provided that no Grantor may assign, transfer
or delegate any of its rights or obligations under this Agreement without the prior written consent of the Agent (given in accordance
with Section 7.1).

 

SECTION
7.7. Signatures; Counterparts. Facsimile or electronic transmissions of any executed original document and/or retransmission
of any executed facsimile or electronic transmission shall be deemed to be the same as the delivery of an executed original. At
the request of any party hereto, the other parties hereto shall confirm such transmissions by executing duplicate original documents
and delivering the same to the requesting party or parties. This Agreement may be executed in any number of counterparts and by
the parties hereto in separate counterparts, each of which when so executed shall be deemed to be an original and all of which
taken together shall constitute one and the same agreement.

 

SECTION
7.8. Severability. If any one or more of the provisions contained in this Agreement, or the application thereof in any
circumstance, is held invalid, illegal or unenforceable in any respect for any reason, the validity, legality and enforceability
of any such provision in every other respect and of the remaining provisions hereof shall not be in any way impaired, unless the
provisions held invalid, illegal or unenforceable shall substantially impair the benefits of the remaining provisions of this
Agreement. The parties hereto further agree to replace such invalid, illegal or unenforceable provision of this Agreement with
a valid, legal and enforceable provision that will achieve, to the extent possible, the economic, business and other purposes
of such invalid, illegal or unenforceable provision.

 

    	 	20	 

     

    

 

SECTION
7.9. Section Heading. The Section headings used in this Agreement are for convenience of reference only and are not to
affect the construction hereof or be taken into consideration in the interpretation hereof.

 

SECTION
7.10. Integration. This Agreement, together with the exhibits and schedules hereto and the other Transaction Documents,
is intended by the parties as a final expression of their agreement and intended to be a complete and exclusive statement of the
agreement and understanding of the parties hereto in respect of the subject matter contained herein and therein. There are no
restrictions, promises, warranties or undertakings, other than those set forth or referred to herein or therein. This Agreement,
together with the exhibits and schedules hereto, and the other Transaction Documents supersede all prior agreements and understandings
between the parties with respect to such subject matter.

 

SECTION
7.11. Governing Law. THIS AGREEMENT SHALL BE GOVERNED BY, CONSTRUED IN ACCORDANCE WITH, AND ENFORCED UNDER, THE LAWS OF
THE STATE OF FLORIDA, WITHOUT REGARD TO THE PRINCIPLES OF CONFLICTS OF LAW OF SUCH STATE.

 

SECTION
7.12. Jurisdiction, Jury Trial Waiver, Etc.

 

(a)
EACH PARTY TO THIS AGREEMENT HEREBY IRREVOCABLY AGREES THAT ANY LEGAL ACTION OR PROCEEDING ARISING OUT OF OR RELATING TO THIS
AGREEMENT, THE OTHER TRANSACTION DOCUMENTS OR ANY AGREEMENTS OR TRANSACTIONS CONTEMPLATED HEREBY OR THEREBY MAY BE BROUGHT IN
THE COURTS OF THE STATE OF FLORIDA OR OF THE UNITED STATES OF AMERICA LOCATED IN TAMPA, FLORIDA AND HEREBY EXPRESSLY SUBMITS TO
THE PERSONAL JURISDICTION AND VENUE OF SUCH COURTS FOR THE PURPOSES THEREOF AND EXPRESSLY WAIVES ANY CLAIM OF IMPROPER VENUE AND
ANY CLAIM THAT ANY SUCH COURT IS AN INCONVENIENT FORUM. EACH PARTY HEREBY IRREVOCABLY CONSENTS TO THE SERVICE OF PROCESS OF ANY
OF THE AFOREMENTIONED COURTS IN ANY SUCH SUIT, ACTION OR PROCEEDING BY THE MAILING OF COPIES THEREOF BY REGISTERED OR CERTIFIED
MAIL, POSTAGE PREPAID, TO ITS ADDRESS SET FORTH IN THE PURCHASE AGREEMENT, SUCH SERVICE TO BECOME EFFECTIVE 10 DAYS AFTER SUCH
MAILING.

 

(b)
TO THE EXTENT PERMITTED BY APPLICABLE LAW, EACH GRANTOR HEREBY WAIVES ITS RIGHT TO A JURY TRIAL WITH RESPECT TO ANY ACTION OR
CLAIM ARISING OUT OF ANY DISPUTE IN CONNECTION WITH THIS AGREEMENT, THE OTHER TRANSACTION DOCUMENTS OR ANY OF THE OTHER TRANSACTION
DOCUMENTS, ANY RIGHTS OR OBLIGATIONS HEREUNDER OR THEREUNDER OR THE PERFORMANCE OF SUCH RIGHTS AND OBLIGATIONS. EACH GRANTOR (i)
CERTIFIES THAT NO REPRESENTATIVE, AGENT OR ATTORNEY OF THE AGENT HAS REPRESENTED, EXPRESSLY OR OTHERWISE, THAT THE AGENT WOULD
NOT, IN THE EVENT OF LITIGATION, SEEK TO ENFORCE THE FOREGOING WAIVERS AND (ii) ACKNOWLEDGES THAT THE AGENT HAS BEEN INDUCED TO
ENTER INTO THIS AGREEMENT, AND THE OTHER TRANSACTION DOCUMENTS TO WHICH IT IS PARTY BY, AMONG OTHER THINGS, THE WAIVERS AND CERTIFICATIONS
CONTAINED HEREIN.

    	 	21	 

     

    

 

SECTION
7.13. Acknowledgements.

 

(a)
Each Grantor hereby acknowledges that:

 

(i)
it has been advised by counsel in the negotiation, execution and delivery of this Agreement and the other Transaction Documents
to which it is a party;

 

(ii)
it has received a copy of the Purchase Agreement and has reviewed and understands the same;

 

(iii)
neither the Agent nor any other Secured Party has any fiduciary relationship with or duty to the Grantor arising out of or in
connection with this Agreement or any of the other Transaction Documents, and the relationship between the Grantors, on the one
hand, and the Agent and the other Secured Parties, on the other hand, in connection herewith or therewith is solely that of debtor
and creditor; and

 

(iv)
no joint venture is created hereby or by the other Transaction Documents or otherwise exists by virtue of the transactions contemplated
hereby or thereby among the Secured Parties or among the Grantors and the Secured Parties.

 

SECTION
7.14. Additional Grantors. The Grantors shall cause each subsidiary formed or acquired after the date hereof, to become
a party to this Agreement and shall execute such other documents as the Agent may request.

 

SECTION
7.15. Releases. At such time as the Obligations shall have been paid in full in cash, and any commitment to make an Advance
has been terminated, the Collateral shall be released from the Liens created hereby, and this Agreement and all obligations (other
than those expressly stated to survive such termination) of the Agent, the other Secured Parties and each Grantor hereunder shall
terminate, all without delivery of any instrument or performance of any act by any party, and all rights to the Collateral shall
revert to the Grantors. At the request and sole expense of the Grantor following any such termination, the Agent shall deliver
to any Grantor any Collateral held by the Agent hereunder, and execute and deliver to such Grantor such documents as such Grantor
shall reasonably request to evidence such termination.

 

SECTION
7.16. No Conflicts with Enforcement; Release. The parties acknowledge that some or all of the Secured Parties and their
respective affiliates are among the Company’s shareholders, and that these relationships will not in any way affect the
Agent’s or other Secured Parties’ rights under this Agreement and as a creditor with respect to the Obligations. The
Company and each Secured Party acknowledge that the Company received proceeds of the extension of credit under the Purchase Agreement
and the Notes in arm’s length transaction approved by the Company’s Board of Directors and required shareholders,
if any, and each Secured Party, with the advice of separate counsel. Each party to this Agreement acknowledges that it has received
substantial benefits from funds furnished to the Company by the Secured Parties and transactions occurring on the date of this
Agreement, including the Company receiving funds that it needed to operate. Each party remises, releases and discharges each Secured
Party for any claim for any lender liability, equitable subordination, or other claim, loss, damage, or remedy, including without
limitation any such claim arising from the transactions contemplated by the Transaction Documents or the Company’s operations
and governance, and further acknowledge that the Company will not be entitled to concessions, extensions or otherwise because
of Secured Parties’ or their affiliate’s relationship to the Company. The Secured Parties may enforce the terms and
provisions of any Transaction Document without regard to the fact that the Secured Parties or their affiliates are shareholders
of the Company.

 

[Signature
Pages to Follow]

 

    	 	22	 

     

    

 

IN
WITNESS WHEREOF, the parties hereto have caused this Security Agreement to be executed under seal by their duly authorized officers,
all as of the day and year first written above.

 

	 	Grantor:

                                                                                 

	 	H-CYTE,
    INC., 
	 	a
    Nevada corporation
	 	 
	 	By:	
	 	Name:	William
    E. Horne
	 	Title:	Chief
    Executive Officer

 

Signature
Page to Security Agreement

 

    	 	 	 

    	 	 	 

    

 

	 	Grantor:

                                                                                 

	 	H-CYTE
                                         MANAGEMENT LLC,

        

	 	a
    Delaware limited liability company
	 	 
	 	By:	
	 	Name:	            
	 	Title:	            

 

Signature
Page to Security Agreement

 

    	 	 	 

    	 	 	 

    

 

	 	Grantor:

                                                                                 

	 	LUNG
                                         INSTITUTE TAMPA, LLC,

        

	 	a
    Delaware limited liability company
	 	 
	 	By:	
	 	Name:	        
	 	Title:	

 

Signature
Page to Security Agreement

 

    	 	 	 

    	 	 	 

    

 

	 	Grantor:

                                                                                 

	 	COGNITIVE
                                         HEALTH INSTITUTE TAMPA, LLC,

        

	 	a
    Delaware limited liability company
	 	 
	 	By:	
	 	Name:	       
	 	Title:	

 

Signature
Page to Security Agreement

 

    	 	 	 

    	 	 	 

    

 

	 	Grantor:

                                                                                 

	 	MEDOVEX
                                         CORP.,

        

	 	a
    Nevada corporation
	 	 
	 	By:	
	 	Name:	      
	 	Title:	

 

Signature
Page to Security Agreement

 

    	 	 	 

    	 	 	 

    

 

	 	Agent:

                                                                                 

	 	FHWC
                                         BRIDGE, LLC,

        

	 	a
    Delaware limited liability company
	 	 
	 	By:	
	 	Name:	Todd
                                         R. Wagner

	 	Title:	Manager

 

Signature
Page to Security Agreement

 

    	 	 	 

    	 	 	 

    

 

SCHEDULE
3.7

 

Names,
States of Organization, Places of Business, Chief Executive Offices, Location of Inventory, Equipment and Fixtures

 

H-Cyte,
Inc.

201
E. Kennedy Blvd, Suite 700

Tampa,
FL 33602

 

H-Cyte
Management LLC

201
E. Kennedy Blvd, Suite 700

Tampa,
FL 33602

 

Lung
Institute Tampa, LLC

201
E. Kennedy Blvd, Suite 700

Tampa,
FL 33602

 

Cognitive
Health Institute Tampa, LLC

201
E. Kennedy Blvd, Suite 700

Tampa,
FL 33602

 

Medovex
Corp.

201
E. Kennedy Blvd, Suite 700

Tampa,
FL 33602Exhibit 10.5 

 

INTELLECTUAL
PROPERTY SECURITY AGREEMENT

 

THIS
INTELLECTUAL PROPERTY SECURITY AGREEMENT (as amended, restated, supplemented or otherwise modified from time to time, the
“Agreement”) is made and entered into as of April 17, 2020 by and between H-CYTE, INC., a Nevada corporation
f/k/a Medovex Corp. (the “Grantor”), having an address at 201 E. Kennedy Blvd., Suite 700, Tampa, FL 33602,
in favor of FWHC BRIDGE, LLC, a Delaware limited liability company, as collateral agent for the ratable benefit of itself
and the other Purchasers under the Purchase Agreement, having an address at 1306 W. Kennedy Blvd., Tampa, Florida 33606 (the “Secured
Party”).

 

WHEREAS,
pursuant to that certain Secured Convertible Note and Warrant Purchase Agreement, dated as of the date hereof, between Grantor
and Secured Party (as amended, supplemented, restated or otherwise modified from time to time, the “Purchase Agreement”),
the Secured Party has agreed to advance funds to the Grantor upon the terms and subject to the conditions set forth therein;

 

WHEREAS,
the Grantor has executed and delivered a Security Agreement, dated as of the date hereof, in favor of the Secured Party (as amended,
supplemented, restated or otherwise modified from time to time, the “Security Agreement”); and

 

WHEREAS,
pursuant to the Security Agreement, the Grantor has granted to the Secured Party a security interest in, inter alia, certain intellectual
property, including the intellectual property set forth on Exhibit A hereto.

 

NOW,
THEREFORE, for good and valuable consideration, the receipt of which is hereby acknowledged, the Grantor agrees as follows:

 

1.
Definitions. Unless otherwise defined herein or the context otherwise requires, terms used in this Agreement, including
its preamble and recitals, have the meanings provided or provided by reference in the Security Agreement, as applicable.

 

2.
Grant of Security Interest for Obligations. The Grantor hereby grants a security interest in, all of such Grantor’s
right, title and interest in, to and under the intellectual property constituting Collateral (including, without limitation, those
items listed on Exhibit A hereto and all goodwill related thereto) (collectively, the “IP Collateral”),
to the Secured Party, as collateral security for the prompt and complete payment and performance when due (whether at the stated
maturity, by acceleration or otherwise) of the Secured Obligations.

 

3.
Purpose. This Agreement has been executed and delivered by the Grantor for the purpose of recording the grant of security
interest herein with the United States Patent and Trademark Office. The security interest granted hereby has been granted to the
Secured Party in connection with the Security Agreement and is expressly subject to the terms and conditions thereof. The Security
Agreement (and all rights and remedies of the Secured Party thereunder) shall remain in full force and effect in accordance with
its terms.

 

4.
Acknowledgment. The Grantor does hereby further acknowledge and affirm that the rights and remedies of the Secured Party
with respect to the security interest in the IP Collateral granted hereby are more fully set forth in the Security Agreement,
the terms and provisions of which (including the remedies provided for therein) are incorporated by reference herein as if fully
set forth herein. In the event of any conflict between this Agreement and the Security Agreement, the terms of the Security Agreement
shall govern.

 

[Signature
Page Follows]

 

    	 	 	 

    	 	 	 

    

 

IN
WITNESS WHEREOF, the Grantor has caused this Agreement to be duly executed and delivered as of the date first above written.

 

	 	GRANTOR:

                                                                      

	 	H-CYTE,
    INC., 
	 	a
    Nevada corporation
	 	 	 
	 	By:
    	
	 	Name:
	William
    E. Horne
	 	Title:
	Chief
    Executive Officer

 

Signature Page to Intellectual Property Security
Agreement

 

    	 	 	 

    	 	 	 

    

 

Exhibit
A

 

IP
COLLATERAL

 

Patents

 

	Patent	 	Serial /
 Registration Number
	 	Filing/
 Registration Date
	 	Owner	 	Filing Location
	Surgical portal driver	 	D870,887	 	12/24/2019	 	Medovex Corp.	 	USPTO
	Surgical tools for spinal facet therapy to alleviate pain and related methods	 	10,398,494	 	9/3/2019	 	Medovex Corp.	 	USPTO
	Surgical portal driver	 	D854,150	 	7/16/2019	 	Medovex Corp.	 	USPTO
	Surgical tools for spinal facet therapy to alleviate pain and related methods	 	9,980,771	 	5/29/2018	 	Medovex Corp.	 	USPTO
	Surgical portal driver	 	D810,290	 	2/13/2018	 	Medovex Corp.	 	USPTO
	Minimally invasive methods for spinal facet therapy to alleviate pain and associated surgical tools, kits and instructional media	 	9,883,882	 	2/6/2018	 	Medovex Corp.	 	USPTO
	Surgical Tools with Positional Components	 	10,595,919	 	3/24/2020	 	Medovex Corp.	 	USPTO
	Surgical Tools for Spinal Facet Therapy to Alleviate Pain and Related Methods	 	10,588,688	 	3/17/2020	 	Medovex Corp.	 	USPTO
	Transformable Intravenous Pole and Boom Combination and Method Thereof	 	9,707,334	 	7/18/2017	 	Medovex Corp.	 	USPTO
	Surgical Tools for Spinal Facet Therapy to Alleviate Pain	 	16/520,738	 	7/24/2019	 	Medovex Corp.	 	USPTO
	Minimally Invasive Methods for Spinal Facet Therapy to Alleviate Pain	 	15/850,662	 	12/21/2017	 	Medovex Corp.	 	USPTO
	Minimally Invasive Methods for Spinal Facet Therapy to Alleviate Pain	 	15/850,630	 	12/21/2017	 	Medovex Corp.	 	USPTO

 

    	 	 	 

    	 	 	 

    

 

Trademarks

 

	Mark	 	Trademark /
 Application
	 	Serial /
 Registration Number
	 	Filing /
 Registration Date
	 	Owner	 	Filing Location
	ANTI-INFLAMMATORY INITIATIVE	 	Trademark	 	5887324	 	10/15/2019	 	H-Cyte, Inc.	 	USPTO
	H-CYTE	 	Application	 	88459878	 	6/5/2019	 	Medovex Corp.	 	USPTO
	BREATHE EASIER	 	Trademark	 	5981349	 	2/11/2020	 	Medovex Corp.	 	USPTO
		 	Application	 	88576562	 	8/13/2019	 	Medovex Corp.	 	USPTO
	LUNG RESTORATION TREATMENT PLUS	 	Trademark	 	5952853	 	1/7/2020	 	Medovex Corp.	 	USPTO
		 	Trademark	 	5948228	 	12/31/2019	 	Medovex Corp.	 	USPTO
	L-CYTE	 	Application	 	88459880	 	6/5/2019	 	Medovex Corp.	 	USPTO
	LUNGCYTE	 	Application	 	88459879	 	11/12/2019	 	Medovex Corp.	 	USPTO
	LUNG MAINTENANCE TREATMENT	 	Trademark	 	5905492	 	11/5/2019	 	Medovex Corp.	 	USPTO
	LUNG HEALTH INSTITUTE	 	Trademark	 	5893510	 	10/22/2019	 	Medovex Corp.	 	USPTO
	ROTACAPSULATION	 	Application	 	87371750	 	3/15/2017	 	Medovex Corp.	 	USPTO
	PULMONARY TRAP	 	Trademark	 	5567463	 	9/18/2018	 	Medovex Corp.	 	USPTO
		 	Trademark	 	5335750	 	11/14/2017	 	Medovex Corp.	 	USPTO
		 	Trademark	 	5317440	 	10/24/2017	 	Medovex Corp.	 	USPTO
	MEDOVEX	 	Trademark	 	5286813	 	9/12/2017	 	Medovex Corp.	 	USPTO
	MEDOVEX CORPORATION	 	Trademark	 	5286578	 	9/12/2017	 	Medovex Corp.	 	USPTO
	DENERVEX	 	Trademark	 	5271510	 	8/22/2017	 	Medovex Corp.	 	USPTO
		 	Trademark	 	4484509	 	2/18/2014	 	Medovex Corp.	 	USPTO

 

Copyrights

 

None.

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00307-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00307-of-00352.parquet"}]]